Omega-3 Fatty Acids in Systemic Health: Cardiovascular Protection, Inflammation Resolution, and the Omega-6/Omega-3 Equilibrium

Empirically validated cardioprotective actions of long-chain marine lipids:

• Triglyceride Lowering: Therapeutic doses of 2 g to 4 g EPA/DHA suppress hepatic sterol regulatory element-binding protein 1c (SREBP-1c), decreasing hepatic VLDL output and dropping serum triglycerides by 20% to 30%.
• Electrophysiological Anti-Arrhythmic Action: Incorporation into sarcolemmal membranes modulates voltage-gated Na+ and L-type Ca2+ channel conductance, shielding the heart against fatal ventricular fibrillation.
• Endothelial Elasticity and Blood Pressure: Stimulates vascular endothelial nitric oxide production, resulting in moderate reductions in systolic and diastolic blood pressure.

Molecular orchestration of inflammation termination mediated by omega-3 SPMs:

• Active Termination Process: Resolution of acute tissue inflammation is driven by Specialized Pro-resolving Mediators (SPMs) synthesized enzymatically from EPA (E-series resolvins) and DHA (D-series resolvins, protectins, maresins).
• Neutrophil Recruitment Cessation: SPMs downregulate endothelial selectin adhesion molecules, halting granulocyte infiltration while promoting non-inflammatory macrophage clearance of cellular debris.
• Systemic Biomarker Attenuation: Consistently lowers circulating high-sensitivity C-reactive protein (hs-CRP), interleukin-1beta, and TNF-alpha across inflammatory pathologies.

Biochemical dynamics governing plant vs marine omega-3 bioavailability:

• Rate-Limiting Endogenous Conversion: The physiological elongation and desaturation of terrestrial alpha-linolenic acid (ALA from flax, chia) to EPA averages only 5% to 8% in humans, with conversion to DHA stalling below 1%.
• Inhibitory Antagonists: Diets overloaded with omega-6 linoleic acid, alcohol intake, and zinc/pyridoxine deficiencies profoundly suppress delta-6 desaturase kinetics.
• Algal Oil Solution: Cold-pressed microalgae oil (cultivated Schizochytrium species) provides direct preformed vegan EPA and DHA matching marine fish oil efficacy.

Diagnostic monitoring and actionable nutritional parameters:

• The Omega-3 Index Metric: Measures the percentage of EPA + DHA in red blood cell membranes. Target cardioprotective threshold is > 8%; an index < 4% reflects high cardiovascular vulnerability.
• Systematic Omega-6 Reduction: Eliminate industrially extracted seed oils (sunflower, corn, soybean) and ultra-processed foods; replace with extra virgin olive oil.
• Strategic Omega-3 Intake: Consume at least two weekly servings of fatty marine fish or supplement with 1000 mg to 1500 mg combined EPA/DHA daily.